Recognizing the significance of Sjögren's disease as a serious and systemic autoimmune disease and expressing support for the designation of April 2025 as "Sjögren's Awareness Month".

Bill Number

H.Res. 245

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Health

Status

Introduced

Latest Action

2025-03-24: Referred to the House Committee on Energy and Commerce.

Last Updated

2025-03-26T12:47:29Z

AI-Generated Summary

Purpose

This House Resolution (H. Res. 245) aims to highlight Sjogren's disease—a systemic autoimmune disorder—as a major health concern affecting millions of Americans. It seeks to raise public and medical awareness about the disease's symptoms, challenges, and the need for better research and diagnosis. Additionally, it expresses support for designating April 2025 as "Sjogren's Awareness Month" to educate communities and encourage action.

Key Provisions

The resolution includes background "Whereas" clauses detailing the disease's prevalence, symptoms, complications, and treatment gaps, followed by a "Resolved" section with three main directives:

• Recognition of the disease: Affirms Sjogren's as a serious health issue causing significant physical, emotional, and economic burdens.
• Encouragement for federal action: Urges the Secretary of Health and Human Services (HHS) and other relevant agencies to:
• Increase research on Sjogren's through the Office of Autoimmune Disease Research, focusing on causes, biomarkers (measurable indicators of the disease), and targeted treatments.
• Improve tracking of patient numbers, as many cases go undiagnosed or misdiagnosed.
• Update and distribute educational materials to healthcare providers to boost awareness and accurate diagnosis.
• Promote awareness among doctors and in underserved communities to ensure timely care.
• Support for awareness month: Endorses April 2025 as "Sjogren's Awareness Month" to foster broader understanding and support for affected individuals.

Significant Changes to Existing Law

This is a non-binding resolution, not a law, so it introduces no enforceable changes to statutes or regulations. It builds on existing federal recognition of autoimmune diseases but adds specific emphasis on Sjogren's without creating new legal obligations.

Potential Impacts

• On government agencies: May indirectly influence HHS and agencies like the National Institutes of Health to prioritize Sjogren's in research budgets, training programs, and public health initiatives, potentially leading to more funding or resources without mandating them.
• On citizens: Could improve diagnosis rates and access to care for the estimated 4 million Americans with Sjogren's (mostly women aged 45-55), reducing out-of-pocket costs and workplace challenges through heightened awareness. Undiagnosed or misdiagnosed individuals, especially in underserved areas, might benefit from better education for patients and families.
• On international relations: No direct impact, as this is a domestic health awareness measure focused on U.S. policy and research.

Main Stakeholders Affected

• Patients and families: Primarily women (9:1 ratio to men) living with Sjogren's, who face symptoms like fatigue, dryness, pain, and complications such as organ damage or lymphoma; they stand to gain from improved diagnosis and treatments.
• Healthcare providers: Rheumatologists, dentists, neurologists, eye specialists, and others involved in care, who may receive updated training and resources to better recognize and treat the disease.
• Researchers and medical organizations: Benefit from calls for expanded studies on causes, genetics, and therapies, potentially accelerating clinical trials.
• Government entities: HHS and related agencies, tasked with enhancing research and awareness efforts.

Notable Legal, Constitutional, or Political Implications

• Legal: As a simple resolution, it has no force of law and requires no presidential approval; it serves as a symbolic statement from the House of Representatives without creating enforceable rights or duties.
• Constitutional: Aligns with Congress's broad authority to address public health issues under its spending and commerce powers but imposes no new mandates, avoiding any separation-of-powers concerns.
• Political: Demonstrates bipartisan support for rare autoimmune diseases, potentially influencing future appropriations or legislation on women's health and chronic illness research. It highlights gaps in federal nomenclature (e.g., classifying Sjogren's explicitly as a "disease") and could build momentum for more substantive policies, such as dedicated funding.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Morelle, Joseph D. [D-NY-25]

Recent Actions

• 2025-03-24: Referred to the House Committee on Energy and Commerce.
• 2025-03-24: Submitted in House
• 2025-03-24: Submitted in House

Bill Versions

• Recognizing the significance of Sjögren’s disease as a serious and systemic autoimmune disease and expressing support for the designation of April 2025 as "Sjögren’s Awareness Month". — issued 2025-03-24 — PDF (4 pages)